Piet van der Graaf and Andrzej Kierzek, Author at Certara

How Modeling & Simulation is Addressing the Immunogenicity Challenge: An academic nicety is now a drug development and regulatory differentiator

2023年1月30日

By Piet van der Graaf and Andrzej Kierzek

Learn how modeling and simulation can help drug developers overcome the immunogenicity challenge, a major hurdle for biologics development and regulatory approval.

QSPを用いた免疫腫瘍学創薬開発の最適化

2019年7月16日

By Piet van der Graaf and Andrzej Kierzek

Immuno-oncology – The Breakthrough in Cancer Therapeutics Cancer immuno-oncology (IO) uses the body’s natural defenses to combat cancer. These therapies stimulate an individual’s immune system and restore its ability to identify and destroy cancer cells. Anti-cancer immune responses are often inhibited during the spread of cancer. Ultimately, IO therapy expedites long term responses against cancer … Continued

Author: Piet van der Graaf and Andrzej Kierzek